Dr. Geoffrey Chupp, director of YCAAD, evaluates and treats each patient's condition individually. Here, pictured in The Center, Dr. Chupp sees patients across a spectrum of airway diseases. Dr.Chupp is at the forefront of asthma and airway disease research. He maintains a compassionate manner in dealing with patients with severe chronic airway illness while keeping an eye toward the ultimate objective of curing asthma.
To provide world class medical treatment to asthmatics and patients with difficult to control asthma and complicated airways disease. Afford to patients for whom conventional controllers have been unsuccessful, the opportunity to participate in innovative research.
YCAAD in the News
- Geoffrey L. Chupp, MD, director of the Yale Center for Asthma and Airways Disease, discusses the biologics of asthma.
- Research in the News: Yale team defines genetic subtypes of asthma
- Los Angeles Times: New Hope For Severe Asthma Sufferers
- Health News Digest: Innovative Breakthrough Treatment for Asthma
- Yale Medical Group: Center is seeking out the best therapies for asthma and airways disease
- Medicine @ Yale: Asthma: from mouse to man and back again
- Baylor Innovations Fort Worth: Air Force
- A breakthrough treatment for severe asthma